InsiderFlow

Reshma Kewalramani

VRTX

Reshma Kewalramani serves as director, officer: CEO & President at Vertex Pharmaceuticals Incorporated (VRTX). This page tracks their complete SEC Form 4 insider trading history including stock purchases and sales.

Total Buys

1 trades

$1.96M

Total Sells

17 trades

$91.54M

Net Position

Net Seller

$89.58M

Companies Traded

1

VRTX

Active Period

Aug 2021 – Mar 2026

18 total trades

Most Recent

Sell VRTX

Mar 3, 2026 · $19.74M

Reshma Kewalramani's Insider Trading at Vertex Pharmaceuticals Incorporated (VRTX)

Buys

1 · $1.96M

Sells

17 · $91.54M

Total Shares Bought

10,000

Total Shares Sold

207,896

VRTX Price Chart
Loading chart...
DateTypeValue
Mar 3, 2026 Sell$19.74M
Feb 17, 2026 Sell$3.17M
Feb 13, 2026 Sell$6.36M
Feb 28, 2025 Sell$6.75M
Nov 12, 2024 Sell$7.83M
Aug 1, 2024 Sell$7.68M
Jul 24, 2024 Sell$7.56M
May 29, 2024 Sell$715.2K
May 22, 2024 Sell$6.80M
Dec 19, 2023 Sell$6.97M
Dec 15, 2023 Sell$2.02M
Nov 15, 2023 Sell$1.92M
Jul 18, 2023 Sell$2.78M
May 1, 2023 Sell$1.12M
Jan 27, 2023 Sell$3.15M
Aug 17, 2022 Sell$3.57M
Jun 28, 2022 Sell$3.41M
Aug 23, 2021 Buy$1.96M